Further research is needed to determine the exact molecular mechanisms of STAMP2 expression by STAT3 and NF-kB signaling crosstalk and how STAMP2 might operate as a survival factor in inflammatory conditions during prostate cancer progression. Here, NFKB1 is linked to prostate carcinoma.